Skip to main content

MoneyWorks4Me

Transgene Biotek incorporates wholly owned subsidiary company

24 Dec 2020 Evaluate

Transgene Biotek has incorporated a wholly owned subsidiary company namely 'Peroral Bio' on December 23, 2020. The company has incorporated a wholly owned subsidiary company for carrying out the business of Pharmaceutical and biotechnology related operations and formulations.

Transgene Biotek (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs.

Peers
Company Name CMP
Sagility 43.70
Prime Focus 274.60
Indegene 665.85
Syngene Internatl. 447.65
Knowledge RealtyTrt. 111.28
View more..